Arthur Rosenthal

Arthur Rosenthal

Directeur/Membre du Conseil chez PROFOUND MEDICAL CORP.

Fortune : 306 048 $ au 31/05/2026

79 ans
Health Technology
Consumer Services
Finance

Profil

Arthur L.
Rosenthal
is the founder of Geyecue Medical Systems Ltd., founded in 2011, serving as Chief Executive Officer.
Dr. Rosenthal was the founder of EyeCue, Inc., founded in 2011, serving as Chief Executive Officer from 2011 to 2015.
Current jobs include Chairman at Arch Biosurgery, Inc. since 2011; Chairman at Interface Biologics, Inc. since 2011; Independent Director at Profound Medical Corp.
since 2018; and Professor at Boston University College of Engineering since 2010.
Former jobs include President & Chief Executive Officer at Cappella, Inc. from 2009 to 2011; Chairman & Chief Executive Officer at Labcoat Ltd. from 2005 to 2008; Executive Vice Chairman at ArraVasc Ltd. from 2011 to 2012; Independent Non-Executive Director at LivaNova USA, Inc. in 2015; Director at HydroCision, Inc.; Non-Executive Director at Ultimate Finance Holdings Ltd. from 2000 to 2010; Director at Tornado Medical Systems, Inc. from 2011 to 2012; Non-Executive Director at Renovo Ltd. from 2000 to 2010; Director at Arch Therapeutics, Inc.; Independent Director at Arch Therapeutics, Inc. from 2011 to 2015; Independent Director at LivaNova Plc from 2015 to 2022; Non-Executive Director at Arch Technologies, Inc. from 2013 to 2015; Venture Advisor at Advent International LP from 2005 to 2007; Vice President-Research & Development at C.
R.
Bard, Inc. (New Jersey); Chief Scientific Officer & Senior Vice President at Boston Scientific Corp.
from 1994 to 2005; Vice President at Davol, Inc. from 1982 to 1991; Chief Scientific Officer at Pfizer Ltd.; Vice President-Research & Development at Johnson & Johnson Medical, Inc. from 1990 to 1994.
Education includes undergraduate degree from the University of Connecticut and doctorate degree from the University of Massachusetts conferred in 1973.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
05/03/2026 44 941 ( 0,12 % ) 306 048 $ 31/05/2026

Postes actifs de Arthur Rosenthal

SociétésPosteDébut
PROFOUND MEDICAL CORP. Directeur/Membre du Conseil 14/06/2018
Corporate Officer/Principal 01/06/2010
Arch Biosurgery, Inc.
Président 01/04/2011
Geyecue Medical Systems Ltd.
Directeur Général 01/12/2011
Président 01/04/2011

Anciens postes connus de Arthur Rosenthal

SociétésPosteFin
LIVANOVA PLC Directeur/Membre du Conseil 13/06/2022
CYBERONICS, INC. Directeur/Membre du Conseil 18/10/2015
ARCH THERAPEUTICS, INC. Directeur/Membre du Conseil 28/05/2015
Directeur/Membre du Conseil 01/05/2015
░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Arthur Rosenthal

Formation de Arthur Rosenthal

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

76

Relations au 1er degré

26

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées26

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Arch Biosurgery, Inc.

Health Technology

Health Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Geyecue Medical Systems Ltd.

Consumer Services

Health Technology

Health Technology

Consumer Durables

EyeCue, Inc.

  1. Bourse
  2. Insiders
  3. Arthur Rosenthal
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇